Privately-held German pharma major Boehringer Ingelheim has unveiled new technology to enhance its contract manufacturing offering in China. 4 July 2018
Acacia Pharma has secured a loan of $30 million from Hercules Technology Growth Capital Inc (Hercules) to support the American launch of its nausea and vomiting therapy Barhemsys (amisulpride). 3 July 2018
The Human Vaccines Project (HVP) announced on June 27 that Seqirus, a global leader in influenza, had joined the project's Universal Influenza Vaccine Initiative (UIVI). 2 July 2018
Astellas Pharma has received an approval for the marketing of Dafclir (fidaxomicin) for the treatment of infectious enteritis (including pseudomembranous colitis) (susceptible strains: fidaxomicin susceptible Clostridium difficile [CD]) in Japan. 2 July 2018
The US District Court for the Eastern District of Pennsylvania, in the case between the Federal Trade Commission and drugmaker AbbVie, has ruled that AbbVie used sham litigation to illegally maintain its monopoly over the testosterone replacement drug AndroGel, and ordered $448 million in monetary relief to consumers who were overcharged for Androgel as a result of AbbVie’s conduct. 30 June 2018
As was forecast earlier this month, a London-based CVC Capital Partners-led consortium of investment funds has agreed to acquire a controlling stake in Recordati, a leading Italian drugmaker that is majority family owned. 30 June 2018
The USA’s Institute for Clinical and Economic Review (ICER) on Wednesday announced the formation of an advisory group to guide the development of a report on US drug price increases that are unsupported by clinical evidence. 28 June 2018
Trade group Medicines Australia has welcomed the introduction of the Therapeutic Goods Amendment (2018 Measures No 1) Bill 2018 into the Parliament today. 28 June 2018
Australian firm Clinuvel Pharmaceuticals has completed the submission of a New Drug Application (NDA) for its drug Scenesse (afamelanotide 16 mg) as the first proposed therapy for patients with the rare metabolic disorder erythropoietic protoporphyria (EPP) in the USA. 26 June 2018
US WorldMeds and Salix Pharmaceuticals, a division of Valeant Pharmaceuticals International, have entered into an exclusive agreement to co-promote US WorldMeds' Lucemyra (lofexidine). 26 June 2018
US drugmaker Pacira Pharmaceuticals has entered into an agreement with Nuance Biotech, a China based specialty pharmaceutical company, to advance the development and commercialization of Exparel (bupivacaine liposome injectable suspension) in China. 21 June 2018
The European Medicines Agency and the European Commission have updated their guidance to help pharmaceutical companies prepare for the UK’s withdrawal from the European Union, which is scheduled for the end of May 2019. 20 June 2018
Independent French drugmaker Ethypharm has appointed Frédéric Molin as executive VP of corporate development, with responsibility for strategic development programs encompassing in-licensing, partnerships and M&A. 20 June 2018
PureTech Health affiliate Karuna Pharmaceuticals, a specialist in disorders marked by psychosis and cognitive symptoms, has been awarded $8 million by the UK’s Wellcome Trust. 20 June 2018
The Canadian branch of Novartis’ generics business, Sandoz, has formed an alliance with Novar Canada and Tilray to boost access to medical cannabis products. 19 June 2018
The International Society for Pharmaceutical Engineering (ISPE) has announced the launch of the ISPE foundation the foundation, a subsidiary philanthropic venture. 19 June 2018
Ortho Dermatologics today announced that it has received a Complete Response Letter (CRL) from the US Food and Drug Administration regarding the company's New Drug Application (NDA) for Duobrii (halobetasol propionate and tazarotene) (IDP-118) lotion in the treatment of plaque psoriasis. 18 June 2018
A new group of British Members of Parliament (MPs) and peers have written to the Chancellor urging her to protect and promote the UK’s world-leading life sciences sector in the government's first Budget, due on October 30. 17 October 2024
The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza Vaccine) to include data from a new safety study involving pregnant women. 17 October 2024
Chengdu Baiyu Pharmaceutical yesterday announced that it has entered into an exclusive license agreement with Swiss pharma giant Novartis for a small molecule anti-tumor asset. 17 October 2024
Shionogi has announced new data at IDWeek 2024 from PROVE (Retrospective Cefiderocol Chart Review), the largest global real-world evidence study of Fetroja/Fetcroja (cefiderocol), an innovative siderophore cephalosporin. 17 October 2024
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
ViiV Healthcare, the specialist HIV company majority owned by GSK, today announced the presentation of new real-world evidence and implementation data showing the effectiveness, adherence, and quality-of-life improvement of Apretude (cabotegravir long-acting (CAB LA)) for HIV pre-exposure prophylaxis (PrEP). 16 October 2024
Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration (FDA)-approved mucoadhesive on the market indicated for the management of pain caused by oral mucositis 16 October 2024
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
US pharma major Eli Lilly has announced a strategic collaboration with two UK government departments and the devolved nations to tackle significant population health challenges, including exploring new models to better care for people living with obesity. 16 October 2024
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Switzerland-based Novocure saw its shares rise 10% yesterday and leap a further 24% to $22.05 pre-market, after the company received a new US regulatory approval for its key product Optune Lua. 16 October 2024
Shares of Spanish drugmaker PharmaMar leapt more than 28% to 63.70 euros today, after it announced positive clinical trial findings for its combo lung cancer treatment, under development with USA-based Jazz Pharmaceuticals, which rose 4.2%. 15 October 2024
Novartis has discontinued an early Phase II trial of LTP001 in idiopathic pulmonary fibrosis (IPF). The company confirmed that the decision was not related to safety, with no issues emerging in the study. 15 October 2024
US pharma major Eli Lilly has announced plans to invest around 1.5 billion renminbi ($206 million) into expanding its manufacturing facility in Suzhou, China. 15 October 2024
Spanish dermatology specialist Almirall (BME: ALM) has announced the successful completion of the decentralized regulatory procedure in Europe for efinaconazole. 15 October 2024
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
India's Central Drugs Standard Control Organization (CDSCO) has provided a favorable recommendation for its novel antibiotic Miqnaf (nafithromycin) discovered and developed for the treatment of community-acquired bacterial pneumonia (CABP) in adults. 14 October 2024